Product Information
SERTRALINE 150 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.3829 per EA under NDC 70954089910. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on Jan 20, 2026. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954089910
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA219714FDA Approved
1/20/2026
TE Code
AB
On Market Since
1/20/2026
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE 150 MG CAPSULE has been published 26 times since Feb 25, 2026, and over the history we have for it it has declined 71.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3829 per EA |
|---|---|
| All-time high | $4.8266 (Mar 11, 2026) |
| All-time low | $1.3829 (Aug 19, 2026) |
| 52-week high | $4.8266 |
| 52-week low | $1.3829 |
| Median price | $3.5570 |
| Average price | $3.5092 |
| Largest weekly change | -33.8% (Jul 22, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SERTRALINE 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 150 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $1.3829 per EA (NDC 70954089910), effective Aug 19, 2026.
How has the price of SERTRALINE 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for SERTRALINE 150 MG CAPSULE has declined 71.3%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for SERTRALINE 150 MG CAPSULE?
Since Feb 25, 2026, the NADAC for SERTRALINE 150 MG CAPSULE has ranged from a low of $1.3829 (Aug 19, 2026) to a high of $4.8266 (Mar 11, 2026), with a median of $3.5570 per EA.
Are there cheaper alternatives to SERTRALINE 150 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SERTRALINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures SERTRALINE 150 MG CAPSULE?
SERTRALINE 150 MG CAPSULE (NDC 70954089910) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.